Chief Medical Officers In Biotechs Finally Have Their Own Conference, 6-7 May 2013, Boston, MA

Date: Mar-19-2013For the first time, Chief Medical Officers at biotechs will have their own conference thanks to the idea from Dr Elizabeth Stoner, Managing Director of MPM Capital. Valerie Bowling, Executive Director of The Conference Forum, the organizer of the event says, "We are grateful to Dr Stoner's idea for the conference and her insights into the unique challenges CMOs face every day at small to mid-size biotechs."    

The Chief Medical Officer Summit takes place in Boston on May 6-7, 2013 and is dedicated to accomplishing two goals:
To bring together CMO executives to address the unique challenges associated with directing and managing all R&D functions with limited resources, while raising capital, working and meeting with investors and strategsing for appropriate exits. 

To create a network of CMOs from small to mid size life science companies to share ideas, solutions and support.

Dr Steven Zelenkofske, CMO & SVP Clinical and Medical Affairs, Regado Biosciences and advisor to the program remarked, "I am excited about this conference and think it is very much needed."

Event Details: May 6-7, Boston, MA 
The event organizers are offering a 10% discount with code CMOE and a pre-early bird rate before 3/1. Click here to register.

Program Overview and Agenda are available at http://www.theconferenceforum.org. 
Questions, please email service(at)theconferenceforum(dot)org

Speaking Faculty: 

Jodi Black, PhD, Deputy Director, Division of Extramural Research Activities, National Heart, Lung, and Blood Institute, NIH 


Mark Corrigan, MD, President & CEO, Zalicus 

Anthony Coyle, PhD, VP & CSO, Centers for Therapeutic Innovation, Pfizer 

Daniel Curran, MD, VP, Corporate Development, Millennium, Takeda Oncology 

Greg Fiore, MD, CMO, The Medicines Company 

Ken Getz, MBA, Senior Research Fellow, Tufts 

Sheila Gujrathi, MD, CMO, Receptos 

M. Scott Harris, MD, CMO, Avaxia Biologics; Principal, Middleburg Consultants; and Clinical Professor of Medicine, Georgetown University School of Medicine 

Eric Hedrick, MD, CMO, Epizyme 
Karin Hehenberger, MD, PhD, Executive Vice President & CMO, Coronado Biosciences 

Dennis Kim, MD, MBA, CMO, Zafgen 

Chris Kiritsy, MBA, President & CEO, Arisaph 

Lori Kunkel, MD, CMO, Pharmacyclics 

Tyler Martin, MD, President, CMO & Director, Dynavax Technologies 

Robert Pyke, MD, PhD, CMO, S1 Biopharma 

Jim Roach, MD, CMO & Senior Vice President, Development, Momenta Pharmaceuticals 

Oscar Segurado, MD, PhD, CMO, Crescendo Bioscience 

Jeffrey Sherman, MD, FACP, CMO & Executive Vice President, Development, Manufacturing, and Regulatory Affairs, Horizon Pharma 

Greg Simon, CEO, Poliwogg 

Elizabeth Stoner, MD, Managing Director, MPM Capital 

Mary Szela, MBA, Senior Vice President, Pharmaceutical Operations, Abbott Laboratories 

Santosh Vetticaden, MD, PhD, CMO, ADVENTRX Pharmaceuticals 

Nancy Wetherbee, MBA, ORBIT Director, Tufts Medical Center 

Steven Zelenkofske, DO, FACC, CMO & Senior Vice President, Clinical and Medical Affairs, Regado Bioscience

Courtesy: Medical News Today Note: Any medical information available in this news section is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional.